Literature DB >> 9040727

Survival of patients with pathologically proven multiple system atrophy: a meta-analysis.

Y Ben-Shlomo1, G K Wenning, F Tison, N P Quinn.   

Abstract

A systematic review of the neurologic literature identified 433 cases of pathologically proven multiple system atrophy over a 100-year period. Earlier case reports included patients younger in age with more frequent cerebellar involvement. Mean age of onset was 54.2 years (range 31 to 78) and survival was 6.2 years (range 0.5 to 24). Survival analysis showed a secular trend from a median duration of 4.9 years for publications between 1887 and 1970 to 6.8 years between 1991 and 1994. Older age of onset was associated with shorter survival; the hazard ratio for patients with onset after 60 years was 1.8 (95% CI 1.4 to 2.3) compared with patients between 31 and 49 years. Cerebellar features were associated with marginally increased survival (6.1 years versus 5.4 years; p = 0.04). There were no difference in survival according to gender, parkinsonian, or pyramidal features or whether the patient was classified as striatonigral degeneration or olivopontocerebellar atrophy type. These results demonstrate the poor prognosis for patients with multiple system atrophy but may be biased toward the worst cases. Future research needs to recruit more representative samples.

Entities:  

Mesh:

Year:  1997        PMID: 9040727     DOI: 10.1212/wnl.48.2.384

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  47 in total

Review 1.  Epidemiological evidence on multiple system atrophy.

Authors:  N Vanacore
Journal:  J Neural Transm (Vienna)       Date:  2005-12       Impact factor: 3.575

Review 2.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

3.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

4.  Abnormal metabolic network activity in REM sleep behavior disorder.

Authors:  Florian Holtbernd; Jean-François Gagnon; Ron B Postuma; Yilong Ma; Chris C Tang; Andrew Feigin; Vijay Dhawan; Mélanie Vendette; Jean-Paul Soucy; David Eidelberg; Jacques Montplaisir
Journal:  Neurology       Date:  2014-01-22       Impact factor: 9.910

5.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

Review 6.  Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Virginia M-Y Lee
Journal:  Neurobiol Dis       Date:  2017-07-24       Impact factor: 5.996

7.  Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.

Authors:  G K Wenning; I Litvan; J Jankovic; R Granata; C A Mangone; A McKee; W Poewe; K Jellinger; K Ray Chaudhuri; L D'Olhaberriague; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

8.  Sex and gender influence symptom manifestation and survival in multiple system atrophy.

Authors:  Elizabeth A Coon; Renee M Nelson; David M Sletten; Mariana D Suarez; J Eric Ahlskog; Eduardo E Benarroch; Paola Sandroni; Jay N Mandrekar; Phillip A Low; Wolfgang Singer
Journal:  Auton Neurosci       Date:  2019-04-24       Impact factor: 3.145

9.  Survival in synucleinopathies: A prospective cohort study.

Authors:  David S Goldstein; Courtney Holmes; Yehonatan Sharabi; Tianxia Wu
Journal:  Neurology       Date:  2015-10-02       Impact factor: 9.910

10.  Mortality and prognosis in patients with neurogenic orthostatic hypotension.

Authors:  Simona Maule; Valeria Milazzo; Milena Maria Maule; Cristina Di Stefano; Alberto Milan; Franco Veglio
Journal:  Funct Neurol       Date:  2012 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.